Medicare Part D coverage · treprostinil · RxCUI 2714668
treprostinil 0.053 MG Inhalation Powder [Yutrepia]
Per the CMS 2026 Part D formulary file, treprostinil 0.053 MG Inhalation Powder [Yutrepia] is covered by 756 Medicare Part D plans (15% of enrollable products), averaging Tier 4.2, with prior authorization required on 97% of covering formularies.
- 15%
- Plan coverage
- 756
- Plans covering
- T4.2
- Avg tier
- 97%
- Prior auth required
What the CMS Formulary Data Shows for treprostinil 0.053 MG Inhalation Powder [Yutrepia]
Per the CMS 2026 Part D formulary file, treprostinil 0.053 MG Inhalation Powder [Yutrepia] (RxNorm concept RXCUI 2714668, generic name treprostinil) appears on 66 distinct formulary files spanning 756 Medicare Part D plan offerings - 15% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.2.
Real-world access to treprostinil 0.053 MG Inhalation Powder [Yutrepia] depends on utilization management as much as tier placement: 97% of covering formularies require prior authorization. 0% require step therapy. 80.3% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 3,017 Part D beneficiaries filled treprostinil 0.053 MG Inhalation Powder [Yutrepia] in 2023, with total plan-and-beneficiary spending of $436,921,533 and an average per-beneficiary annual cost of $144,819.87. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry treprostinil 0.053 MG Inhalation Powder [Yutrepia] today.
Coverage Details
- Formularies covering
- 66
- Plans covering
- 756
- Coverage rate
- 15%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 97% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 80.3% of formularies
2023 Medicare Spending
- Beneficiaries
- 3,017
- Total spending
- $436,921,533
- Avg per beneficiary
- $144,819.87
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering treprostinil 0.053 MG Inhalation Powder [Yutrepia]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Florida Complete Care-Duals VIP (HMO-POS D-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $0 | FL |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Elderplan Plus Long-Term Care (HMO-POS D-SNP) | Elderplan, Inc. | T1 | Yes | $0 | NY |
| Health Choice Pathway (HMO D-SNP) | Health Choice Arizona, Inc. | T1 | Yes | $0 | AZ |
| Healthfirst CompleteCare (HMO D-SNP) | Healthfirst Health Plan, Inc. | T1 | Yes | $0 | NY |
| IMCare Classic (HMO D-SNP) | Itasca Medical Care | T1 | Yes | $0 | MN |
| Johns Hopkins Advantage MD D-SNP (HMO D-SNP) | Hopkins Health Advantage, Inc. | T1 | Yes | $0 | MD |
| MetroPlus UltraCare (HMO D-SNP) | Metroplus Health Plan, Inc. | T1 | Yes | $0 | NY |
| Senior Whole Health SCO (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Senior Whole Health SCO NHC (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Molina One Care (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | Yes | $0 | CA |
| CCA One Care (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | Yes | $0 | MA |
| CCA Senior Care Options (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | Yes | $0 | MA |
| Florida Complete Care (HMO I-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $4.80 | FL |
| Florida Complete Care- In The Community (HMO-POS I-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $4.80 | FL |
Show the next 30 plans
| Elderplan For Medicaid Beneficiaries (HMO-POS D-SNP) | Elderplan, Inc. | T1 | Yes | $22.70 | NY |
| VIVA Medicare Extra Value (HMO D-SNP) | Viva Health, Inc. | T1 | Yes | $27.70 | AL |
| VIVA Medicare Extra Care (HMO D-SNP) | Viva Health, Inc. | T1 | Yes | $27.70 | AL |
| Elderplan Advantage For Nursing Home Residents (HMO-POS I-SNP) | Elderplan, Inc. | T1 | Yes | $44.80 | NY |
| MetroPlus Platinum Plan (HMO) | Metroplus Health Plan, Inc. | T1 | Yes | $58.80 | NY |
| Sharp Direct Advantage Gold (HMO) | Sharp Health Plan | T5 | Yes | $0 | CA |
| Sharp Direct Advantage VIP (HMO) | Sharp Health Plan | T5 | Yes | $0 | CA |
| Sharp Direct Advantage VIP Plus (HMO) | Sharp Health Plan | T5 | Yes | $0 | CA |
| Blue Medicare Advantage PPO (PPO) | Wellmark Advantage Health Plan, Inc. | T5 | Yes | $0 | IA |
| BlueMedicare Premier (HMO) | Usable HMO, Inc. | T5 | Yes | $0 | AR |
| BlueMedicare Classic Plus (HMO) | Usable HMO, Inc. | T5 | Yes | $0 | AR |
| Medicare HMO Blue SaverRx (HMO-POS) | Bcbs OF Massachusetts HMO Blue, Inc. | T5 | Yes | $0 | MA |
| Clever Care Longevity (HMO) | Clever Care OF Golden State, Inc. | T5 | Yes | $0 | CA |
| Clever Care Value (HMO) | Clever Care OF Golden State, Inc. | T5 | Yes | $0 | CA |
| Clever Care Total+ (HMO C-SNP) | Clever Care OF Golden State, Inc. | T5 | Yes | $0 | CA |
| Clever Care Breathe+ (HMO C-SNP) | Clever Care OF Golden State, Inc. | T5 | Yes | $0 | CA |
| Clover Health Choice (PPO) | Clover Insurance Company | T5 | Yes | $0 | TX |
| Clover Health LiveHealthy (PPO) | Clover Insurance Company | T5 | Yes | $0 | GA |
| Clover Health LiveHealthy (PPO) | Clover Insurance Company | T5 | Yes | $0 | SC |
| Clover Health Choice (PPO) | Clover Insurance Company | T5 | Yes | $0 | PA |
| Clover Health LiveHealthy Giveback (PPO) | Clover Insurance Company | T5 | Yes | $0 | GA, SC |
| Clover Health Choice (PPO) | Clover Insurance Company | T5 | Yes | $0 | NJ |
| Clover Health Choice (PPO) | Clover Insurance Company | T5 | Yes | $0 | NJ |
| Clover Health Choice Giveback (PPO) | Clover Insurance Company | T5 | Yes | $0 | NJ |
| Clover Health Classic (HMO) | Clover HMO OF NEW Jersey Inc. | T5 | Yes | $0 | NJ |
| Elderplan Flex (HMO-POS) | Elderplan, Inc. | T5 | Yes | $0 | NY |
| Elderplan Select (HMO-POS I-SNP) | Elderplan, Inc. | T5 | Yes | $0 | NY |
| Healthfirst Life Improvement Plan (HMO D-SNP) | Healthfirst Health Plan, Inc. | T5 | Yes | $0 | NY |
| Healthfirst Connection Plan (HMO D-SNP) | Healthfirst Health Plan, Inc. | T5 | Yes | $0 | NY |
| Healthfirst 65 Plus Plan (HMO) | Healthfirst Health Plan, Inc. | T5 | Yes | $0 | NY |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is treprostinil 0.053 MG Inhalation Powder [Yutrepia] covered by Medicare Part D?
Yes, treprostinil 0.053 MG Inhalation Powder [Yutrepia] is covered by 756 Medicare Part D plans (15% of all Part D formularies).
What tier is treprostinil 0.053 MG Inhalation Powder [Yutrepia] on Medicare Part D plans?
treprostinil 0.053 MG Inhalation Powder [Yutrepia] averages Tier 4.2 across Part D plans, ranging from Tier 1 to Tier 5.
Does treprostinil 0.053 MG Inhalation Powder [Yutrepia] require prior authorization?
97% of Part D formularies require prior authorization for treprostinil 0.053 MG Inhalation Powder [Yutrepia]. Step therapy: 0%. Quantity limits: 80.3%.
How much does Medicare spend on treprostinil 0.053 MG Inhalation Powder [Yutrepia]?
In 2023, total Medicare Part D spending on treprostinil 0.053 MG Inhalation Powder [Yutrepia] was $436,921,533, covering 3,017 beneficiaries. The average spend per beneficiary was $144,819.87.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- everolimus 10 MG Oral Tablet T4.2
- {56 (elexacaftor 50 MG / ivacaftor 37.5 MG / tezacaftor 25 MG Oral Tablet) / 28 (ivacaftor 75 MG Oral Tablet) } Pack [Trikafta (50 MG / 37.5 MG / 25 MG; 75 MG)] T4.2
- 1.5 ML leuprolide acetate 7.5 MG/ML Prefilled Syringe [Lupron] T4.2
- alpha 1-proteinase inhibitor, human 1 MG Injection [Prolastin] T4.2
- ivacaftor 150 MG Oral Tablet [Kalydeco] T4.2
- tenofovir alafenamide 25 MG Oral Tablet [Vemlidy] T4.2